Immunotherapy has become recognized as the fifth pillar of cancer treatment and has revolutionized the field.  However, a key challenge is the ability to effectively and efficiently deliver immunotherapy in a controlled and targeted manner in order to mitigate serious adverse effects such as unwanted inflammation and autoimmunity.  Thus, the development of novel biomaterials and drug delivery systems could have significant impact.

  • IMMUNE 3D® can be used to measure guided or targeted approaches (nanoparticles)
  • Matched immune cell/ solid tumor model systems can be used to assess immune cell infiltration, drug penetrance and surface area coverage
  • Immune cell motility and effector functions as well as tumor cell death can be measured in a qualitative (phenotypic) and quantitative manner.